

Koye Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 32.00 Cr
- Paid Up Capital ₹ 26.93 Cr
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 123.45 Cr
- Satisfied Charges ₹ 127.76 Cr
- Revenue Growth -9.81%
- Profit Growth -346.88%
- Ebitda -565.48%
- Net Worth -387.60%
- Total Assets -8.79%
About Koye Pharmaceuticals
Koye Pharmaceuticals Private Limited (KPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 May 2013 and has a history of 11 years and nine months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 32.00 Cr and a paid-up capital of Rs 26.93 Cr.
The company currently has active open charges totaling ₹123.45 Cr. The company has closed loans amounting to ₹127.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Koye Pharmaceuticals Private Limited India is Mitali Kulkarni as COMPANY SECRETARY. Ravindra Shenoy and Preetish Toraskar serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74120MH2013PTC243214
- Company No.
243214
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Koye Pharmaceuticals Private Limited offer?
Koye Pharmaceuticals Private Limited offers a wide range of products and services, including Health Conditions, Pain Relief, Respiratory Care, Health Food & Drinks, Healthy Snacks, Bone, Joint & Muscle Care, Immunity Boosters, Vitamin C, Popular Category, Bone & Joint Care.
Who are the key members and board of directors at Koye Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mitali Kulkarni | Company Secretary | 23-Jan-2019 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Preetish Toraskar ![]() | Director | 09-Sep-2013 | Current |
Ravindra Shenoy ![]() | Director | 16-Jul-2013 | Current |
Financial Performance of Koye Pharmaceuticals.
Koye Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.81% decrease. The company also saw a substantial fall in profitability, with a 346.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 387.6%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Koye Pharmaceuticals?
In 2023, Koye Pharmaceuticals had a promoter holding of 99.90% and a public holding of 0.10%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Koye Lifesciences Private Limited
Ravindra Shenoy and Preetish Toraskar are mutual person
- Koye Foundation
Ravindra Shenoy and Preetish Toraskar are mutual person
- Wealthurn Enterprises Llp
Ravindra Shenoy is a mutual person
- Koye Enterprises Llp
Ravindra Shenoy and Preetish Toraskar are mutual person
- Wealthurn Estates Llp
Ravindra Shenoy is a mutual person
- Blue Oyster Enterprises Llp
Ravindra Shenoy and Preetish Toraskar are mutual person
Charges (Loans)
₹123.45 Cr
₹127.76 Cr
Charges Breakdown by Lending Institutions
- Others : 56.85 Cr
- Axis Bank Limited : 41.60 Cr
- Yes Bank Limited : 22.00 Cr
- Tjsb Sahakari Bank Limited : 3.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 Feb 2023 | Others | ₹20.00 Cr | Open |
22 Mar 2022 | Others | ₹36.85 Cr | Open |
22 Feb 2022 | Yes Bank Limited | ₹14.00 Cr | Open |
14 Jan 2022 | Tjsb Sahakari Bank Limited | ₹3.00 Cr | Open |
26 Oct 2021 | Axis Bank Limited | ₹15.00 Cr | Open |
How Many Employees Work at Koye Pharmaceuticals?
Koye Pharmaceuticals has a workforce of 673 employees as of Jan 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Koye Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koye Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Koye Pharmaceuticals
Recent activity within the organization
- Charges
A charge registered on 17 Mar 2022 via Charge ID 100558857 with Others was fully satisfied on 02 Sep 2024.
- Charges
A charge registered on 13 Jul 2020 via Charge ID 100397886 with Others was fully satisfied on 11 Mar 2024.
- Charges
A charge registered on 11 Mar 2020 via Charge ID 100336324 with Others was fully satisfied on 13 Dec 2023.
- Charges
A charge registered on 30 Nov 2018 via Charge ID 100224844 with Others was fully satisfied on 02 Dec 2023.
- Annual General Meeting
Koye Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Koye Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Recent News, Updates & Announcement
- Shake-up in China industry disrupts vitamin C supply in India | Mint.
Supply disruptions have also been witnessed with popular chewable vitamin C tablet, Limcee.Limcee Plus has vitamin C and amino acid and thus does not only target patients who suffer from vitamin C deficiency.
- InnoVen Capital India loaned $12 million to eight start-ups in Q1 | Mint.
InnoVen Capital India aims to disburse about $60-65 million in venture debt in 2016.
Frequently asked questions
What is the Incorporation or founding date of Koye Pharmaceuticals Private Limited?
Koye Pharmaceuticals Private Limited was incorporated on 12 May 2013.
What is authorized share capital and paid-up capital of Koye Pharmaceuticals Private Limited?
The authorized share capital of Koye Pharmaceuticals Private Limited is ₹ 32.00 Cr and paid-up capital is ₹ 26.93 Cr.
Who are the current board members & directors of Koye Pharmaceuticals Private Limited?
Currently 3 directors are associated with Koye Pharmaceuticals Private Limited.
- Ravindra Yogesh Shenoy
- Preetish Mohan Toraskar
- Mitali Mukund Kulkarni
What is the registered address of Koye Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Koye Pharmaceuticals Private Limited is Sf A-01 Art Guild House Phoenix Market City Annexe Lbs Marg Kurla (West), India, Mumbai, Maharashtra, 400070.
What is the corporate identification number (CIN) and company number of Koye Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Koye Pharmaceuticals Private Limited is U74120MH2013PTC243214 and the company number is 243214 as per Ministry of Corporate Affairs (MCA).
What is the official website of Koye Pharmaceuticals Private Limited?
The Official website of Koye Pharmaceuticals Private Limited is https://www.koye.co
What has been the recent revenue trend for Koye Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Koye Pharmaceuticals Private Limited has fallen by -9.81%.
How many employees does Koye Pharmaceuticals Private Limited currently have?
As Per 2023 financial reports, 673 employees are currently employed by Koye Pharmaceuticals Private Limited.
What change has been observed in the net worth of Koye Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Koye Pharmaceuticals Private Limited has experienced an downturn of -387.60%.
What are the total open charges for Koye Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Koye Pharmaceuticals Private Limited amount to ₹ 123.45 Cr.
When was the last Balance Sheet of Koye Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Koye Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
- Rajesh WaderaDirector
- Poonam WaderaDirector
- Nikhil BalaramanNominee Director
- Abhay PandeyNominee Director
AS
Anjana SasidharanNominee DirectorMT
Mohan ToraskarDirectorAG
Atul GuptaNominee DirectorBS
Bharat SinghNominee Director
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Mumbai, Maharashtra, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India